Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lung Perfusion in CF
NCT04467957Phase 4Active, not recruiting
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Nov 2020
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of elexacaftor + tezacaftor + ivacaftor in cystic fibrosis (CF), sponsored by Cincinnati Children's Hospital Medical Center. Started Nov 2020; status: active, not recruiting.
02
Drugs
elexacaftor + tezacaftor + ivacaftor
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT04467957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04467957.